On Thursday, April 13, the head of the UICAR department , Roberto Martín Reyes , participated in the expert debate organized by the Ferrer laboratory.
It addressed the management strategy for acute coronary syndrome (ACS) at discharge, secondary prevention, and the possible benefit of using the polypill.
The management of acute coronary syndrome requires a comprehensive approach that seeks to ensure the complete recovery of patients with coronary heart disease who have suffered an acute coronary event.
The management strategy for ACS upon discharge begins with the early identification of the disease and the implementation of measures to stabilize the patient. This includes administering medications, and performing revascularization procedures to restore blood flow to the heart. Upon discharge, it is essential that patients be taken to cardiac rehabilitation units, as they have been shown to significantly reduce cardiovascular events during follow-up.
In this sense, the polypill is a medication that combines several drugs in a single pill. It is designed to simplify the treatment of patients with chronic diseases and reduce the number of medications they must take daily, thereby promoting adherence to treatment, which has been shown to be essential in reducing cardiovascular events during follow-up according to the latest studies. data published by the SECURE study.
The talk ended with a debate in which different perspectives were addressed, thus concluding a very enriching talk.